Koers Genesis Healthcare, Inc. Deutsche Boerse AG
Aandelen
SH11
US37185X1063
Gezondheidszorgvoorzieningen & -diensten
Omzet 2021 * | 3,46 mld. 3,23 mld. | Omzet 2022 * | - | Marktkapitalisatie | 146K 137K |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 * | -22 mln. -20,55 mln. | Nettowinst (verlies) 2022 * | - | EV/omzet 2021 * | 0,95 x |
Nettoschuld 2021 * | 3,28 mld. 3,06 mld. | Nettoliquiditeiten 2022 * | - 0 | EV/omzet 2022 * | - |
K/w-verhouding 2021 * |
-0,01
x | K/w-verhouding 2022 * |
-
| Werknemers | 44.000 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 * |
-
| Vrij verhandelbaar | 46,99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 01-02-21 | |
Public Communications Contact | - | - | |
Susan Overton
LAW | General Counsel | - | 01-01-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 72 | 02-02-15 | |
John Randazzo
BRD | Director/Board Member | 69 | 02-03-21 |
Chairman | 79 | 02-03-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,11% | 89,18 mld. | |
-26,29% | 76,11 mld. | |
+1,62% | 27,11 mld. | |
-10,44% | 17,13 mld. | |
-0,14% | 16,83 mld. | |
+0,79% | 15,4 mld. | |
+76,56% | 13,68 mld. | |
+79,78% | 13,25 mld. | |
-25,79% | 12,83 mld. |